Information  /  Tobacco industry

Tobacco companies operate in a heavily regulated market, but they still have strong commercial incentives to protect sales and shape how tobacco and nicotine policy is discussed. International public-health guidance recognises industry influence as an issue that governments need to manage transparently.

Last reviewed: 25th September 2026

QUICK ANSWER

The WHO Framework Convention on Tobacco Control says public-health policies on tobacco should be protected from the commercial and other vested interests of the tobacco industry. This principle is set out in Article 5.3 of the treaty.

The aim is not to stop scrutiny or lawful participation in public processes. It is to recognise a conflict between public-health goals and an industry whose profits depend on selling tobacco products.

• Lobbying and policy engagement — seeking to influence the design, timing or scope of regulation.
• Using third parties — working through trade bodies, retailers, consultants, campaign groups or other intermediaries.
• Corporate social responsibility and reputation activity — promoting charitable, environmental or community initiatives alongside commercial interests.
• Questioning or reframing evidence — challenging the strength, relevance or interpretation of public-health evidence.
• Illicit-trade arguments — using concerns about smuggling or illegal sales in debates about tobacco-control measures.
• New-product positioning — presenting newer nicotine or tobacco products as part of a changing market and seeking different regulatory treatment for them.

Product design, branding, flavours, retailer visibility, creator-style content and repeated online exposure can affect how tobacco, vaping and nicotine products are perceived. That is different from policy influence, but the two sit within the same wider commercial environment.

Read our guide to marketing and digital influence

Article 5.3 is part of the WHO Framework Convention on Tobacco Control, an international treaty. It says Parties should protect tobacco-control policy from the commercial and vested interests of the tobacco industry, in line with national law.

WHO guidance linked to Article 5.3 recommends transparency around necessary interactions with the industry and measures to avoid conflicts of interest.

Industry arguments can appear in debates about taxation, packaging, advertising, product standards, retailer rules, illicit trade and newer nicotine products. The presence of an industry viewpoint does not by itself tell you whether a claim is right or wrong; the useful questions are who is making the claim, what evidence supports it, what interests are involved and whether independent evidence points the same way.

Illegal tobacco and vapes
Tobacco and Vapes Act 2026

• WHO FCTC: Article 5.3 and tobacco-industry interference
• WHO FCTC: tobacco-industry interference and tactics
• ASH: briefing on the tobacco industry and its tactics
• Tobacco Tactics, University of Bath